---
figid: PMC6330346__fphar-09-01520-g003
figlink: /pmc/articles/PMC6330346/figure/F3/
number: F3
caption: Rapamycin inhibits the de-differentiation of vascular smooth muscle cells.
  Rapamycin suppresses the de-differentiation of vascular smooth muscle cells by inhibiting
  the activation of mTOR and S6K1, activating PI3K/AKT pathways, inhibiting PDGF pathway
  and the formation of FGFR-1/FRS2/mTOR complex. In addition, rapamycin inhibits the
  synthesis of hyaluronan through decreasing HAS and the secretion of VEGF. The solid
  lines with arrow and notation ↑ indicate increase or activation, and lines without
  arrows indicate decrease or suppression. VSMC, vascular smooth muscle cell; S6K1,
  ribosomal protein S6 kinase 1; mTOR, mammalian target of rapamycin; IFN-γ, interferon-γ;
  IL-1β, interleukin-1β; VEGF, vascular endothelial growth factor; RAPA, rapamycin;
  HAS, hyaluronan synthase; α-SMA, α-smooth muscle actin; SM-MHC, smooth muscle-myosin
  heavy chain; FGFR1, fibroblast growth factor receptor 1; FRS2, fibroblast growth
  factor receptor substrate 2; FGF, fibroblast growth factor; IGF, insulin-like growth
  factor; PDGF, platelet-derived growth factor.
pmcid: PMC6330346
papertitle: 'Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic
  Effects and Its Clinical Application.'
reftext: Yandong Liu, et al. Front Pharmacol. 2018;9:1520.
pmc_ranked_result_index: '142932'
pathway_score: 0.9647337
filename: fphar-09-01520-g003.jpg
figtitle: Rapamycin inhibits the de-differentiation of vascular smooth muscle cells
year: '2018'
organisms:
- Homo sapiens
ndex: 9e31f020-ded3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6330346__fphar-09-01520-g003.html
  '@type': Dataset
  description: Rapamycin inhibits the de-differentiation of vascular smooth muscle
    cells. Rapamycin suppresses the de-differentiation of vascular smooth muscle cells
    by inhibiting the activation of mTOR and S6K1, activating PI3K/AKT pathways, inhibiting
    PDGF pathway and the formation of FGFR-1/FRS2/mTOR complex. In addition, rapamycin
    inhibits the synthesis of hyaluronan through decreasing HAS and the secretion
    of VEGF. The solid lines with arrow and notation ↑ indicate increase or activation,
    and lines without arrows indicate decrease or suppression. VSMC, vascular smooth
    muscle cell; S6K1, ribosomal protein S6 kinase 1; mTOR, mammalian target of rapamycin;
    IFN-γ, interferon-γ; IL-1β, interleukin-1β; VEGF, vascular endothelial growth
    factor; RAPA, rapamycin; HAS, hyaluronan synthase; α-SMA, α-smooth muscle actin;
    SM-MHC, smooth muscle-myosin heavy chain; FGFR1, fibroblast growth factor receptor
    1; FRS2, fibroblast growth factor receptor substrate 2; FGF, fibroblast growth
    factor; IGF, insulin-like growth factor; PDGF, platelet-derived growth factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFA
  - IL1B
  - MTOR
  - AKT2
  - AKT3
  - FGF1
  - AKT1
  - FGF3
  - FGF5
  - FGF6
  - FGF7
  - FGF16
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF2
  - FGF22
  - FGF4
  - FGF18
  - FGF17
  - PDGFRA
  - FGF19
  - FGFR1
  - FRS2
  - HAS1
  - VEGFD
  - PGF
  - VEGFA
  - VEGFB
  - VEGFC
  - FGF23
  - TRERF1
  - PDGFB
  - PDGFC
  - PDGFRB
  - CDKN1A
  - RPS6KB1
  - MYH11
  - FGF20
  - PDGFD
  - FGF21
  - Cancer
genes:
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGFR1
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FRS2
  symbol: FRS2
  source: hgnc_symbol
  hgnc_symbol: FRS2
  entrez: '10818'
- word: HAS
  symbol: HAS
  source: hgnc_prev_symbol
  hgnc_symbol: HAS1
  entrez: '3036'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: RAPA
  symbol: RAPA
  source: hgnc_alias_symbol
  hgnc_symbol: TRERF1
  entrez: '55809'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: Waf-1
  symbol: WAF1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1A
  entrez: '1026'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: SM-MHC
  symbol: SMMHC
  source: hgnc_alias_symbol
  hgnc_symbol: MYH11
  entrez: '4629'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6330346__F3
redirect_from: /figures/PMC6330346__F3
figtype: Figure
---
